Definitive Contract W911SR20C0049

Award Date 8/3/20
Potential Completion Date 12/31/21
Potential Value $31M
Contracting Federal Agency
ACC Aberdeen Proving Ground
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Marietta, GA 30066, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
16
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This definitive contract awarded by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to Medline Industries, LP provides for the delivery of safety syringes and needles in support of COVID-19 response efforts. The $8.2 million firm-fixed price contract calls for Medline to supply up to 500 million FDA-approved combination needle and syringe units from its Winnetka, Illinois facility between August 2020 and August 2021. This award fulfills...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded Duopross Meditech Corporation a $47.7 million firm fixed price contract to supply safety syringes and needles in support of the COVID-19 response. Under the contract, Duopross Meditech will provide up to 500 million FDA-approved combination needle and syringe units from its Farmingdale, New York facility by October 2021. The syringes will include approximately 270 million 1ml syringes with 23g...
Quality Impact Inc. was awarded a definitive contract valued at $9,579,101.94 by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to supply safety syringes and needles in support of the COVID-19 response. The firm fixed price contract runs from August 3, 2020 to August 30, 2021 and requires performance in Foster City, California. The solicitation sought up to 500 million FDA-approved combination needle and syringe units or individual sterile needles...
The Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response awarded a $93.8 million firm fixed price delivery order contract to Retractable Technologies Inc. to procure needles and syringes in support of the agency's COVID-19 mass vaccination campaign. Performance will take place in Washington, D.C. over a three-year period concluding in September 2023. As the prime contractor, Retractable Technologies Inc. will deliver the requested medical...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $14.7 million firm fixed price contract to Goldbelt Security LLC under an 8(a) sole source set aside designation. The objective of this contract is to procure 30 million conventional 5 ml syringes and needles in support of Operation Warp Speed, the national program to accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics. Goldbelt...
This federal contract award is for the delivery of COMIRNATY (COVID-19 vaccine) syringes, 0.3 mL, with a ceiling value of $22,005. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). It is a firm fixed-price delivery order contract with an ultimate completion date of November 18, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a for-profit pharmaceutical distribution company, to supply 0.3mL syringes of the COMIRNATY COVID-19 vaccine for individuals aged 12 and up. The contract has a ceiling value of $1,126.71 and a performance period through March 26, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $110,025.00 firm-fixed-price delivery order is for the supply of COMIRNATY (COVID-19 vaccine) syringes for individuals 12 years and older, with a completion date of September 26, 2024. The contract is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support...
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded Becton, Dickinson and Company a $19.2 million firm fixed price delivery order to procure needles and syringes in support of COVID-19 mass vaccination efforts. Performance will take place in Washington, D.C. through September 2023. This order was issued under an existing HHS contract vehicle to supply materials necessary for efficiently administering coronavirus vaccines on a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of COMIRNATY (COVID-19 vaccine) syringes. The contract has a ceiling value of $28,654.15 and a period of performance through September 23, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering...

This definitive contract was awarded by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to HTL Strefa Inc., doing business as HTL Strefa SA, for $31,097,312.77. The prime contractor will supply safety syringes and needles to support the COVID-19 response effort. Performance will take place in Marietta, Georgia from August 3, 2020 through December 31, 2021.

The original solicitation sought proposals for up to five hundred million FDA-approved combination needle and syringe units or individual sterile needles and syringes. Offerors were required to propose a minimum of five million units by December 31, 2020 to be considered technically acceptable. There was no set-aside designation for this competition, which was conducted separately for approximately two hundred seventy million 1ml syringes and two hundred thirty million 3ml syringes.

Generated 12/29/23, 4:37 PM